X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2620) 2620
Publication (194) 194
Conference Proceeding (47) 47
Book Chapter (32) 32
Newspaper Article (32) 32
Book / eBook (28) 28
Dissertation (23) 23
Patent (23) 23
Report (23) 23
Book Review (11) 11
Magazine Article (5) 5
Government Document (2) 2
Paper (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (772) 772
index medicus (537) 537
female (409) 409
male (403) 403
adult (304) 304
middle aged (268) 268
animals (211) 211
surgery (191) 191
transplantation (169) 169
aged (162) 162
analysis (155) 155
research (122) 122
adolescent (116) 116
immunology (104) 104
plant sciences (90) 90
child (88) 88
article (85) 85
wheat (79) 79
studies (76) 76
india (75) 75
health aspects (74) 74
agriculture, dairy & animal science (73) 73
mice (73) 73
agronomy (72) 72
pathology (72) 72
retrospective studies (72) 72
treatment outcome (71) 71
biopsy (67) 67
kidney transplantation (67) 67
time factors (67) 67
risk factors (66) 66
diagnosis (65) 65
microbiology (65) 65
research article (65) 65
management (64) 64
care and treatment (63) 63
veterinary sciences (61) 61
infection (58) 58
medicine (57) 57
food science & technology (56) 56
kidney transplantation - immunology (56) 56
chemistry (55) 55
chemistry, analytical (54) 54
genetics & heredity (54) 54
medicine & public health (54) 54
medicine, general & internal (52) 52
pharmacology & pharmacy (51) 51
usage (51) 51
biochemistry & molecular biology (50) 50
methods (50) 50
disease (49) 49
child, preschool (48) 48
immunosuppressive agents - therapeutic use (47) 47
life sciences (47) 47
follow-up studies (46) 46
graft rejection - pathology (46) 46
aged, 80 and over (45) 45
clinical neurology (45) 45
kidney (45) 45
patients (45) 45
young adult (45) 45
cattle (44) 44
physics (44) 44
prevalence (44) 44
genetic aspects (42) 42
prospective studies (42) 42
rats (42) 42
infectious diseases (41) 41
quality (41) 41
tacrolimus - therapeutic use (41) 41
chemistry, multidisciplinary (40) 40
medical research (40) 40
abridged index medicus (38) 38
cell biology (38) 38
agriculture (37) 37
infant (37) 37
transplantation, homologous (37) 37
dna (36) 36
genes (36) 36
identification (36) 36
immunosuppression (36) 36
pregnancy (36) 36
molecular sequence data (35) 35
mortality (35) 35
rejection (35) 35
canada (34) 34
cancer (34) 34
cardiac & cardiovascular systems (34) 34
chemistry, physical (34) 34
multidisciplinary sciences (34) 34
physiological aspects (34) 34
recipients (34) 34
systematic review (34) 34
therapy (34) 34
united kingdom (34) 34
agriculture, multidisciplinary (33) 33
biotechnology & applied microbiology (33) 33
kidneys (33) 33
orthopedics (33) 33
polymerase chain reaction (33) 33
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (13) 13
UTL at Downsview - May be requested (7) 7
Royal Ontario Museum - Far Eastern (5) 5
Gerstein Science - Stacks (3) 3
Royal Ontario Museum - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
East Asian (Cheng Yu Tung) - Stacks (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Media Commons - Microtexts (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2813) 2813
French (9) 9
German (7) 7
Panjabi (2) 2
Spanish (2) 2
Hindi (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article